業績募集

神経再生医療学部門の業績の紹介です。

Morita T, Sasaki M, Kataoka-Sasaki Y, Nakazaki M, Nagahama H, Oka S, Oshigiri T, Takebayashi T, Yamashita T, Kocsis JD, Honmou O. Intravenous infusion of mesenchymal stem cells promotes functional recovery in a model of chronic spinal cord injury. Neuroscience. 2016 Aug 30. [Epub ahead of print]

Noshiro S, Mikami T, Kataoka-Sasaki Y, Sasaki M, Hashi K, Ohtaki S, Wanibuchi M, Mikuni N, Kocsis JD, Honmou O., Biological relevance of tissue factor and IL-6 in arteriovenous malformations. Neurosurg Rev. 2016 Aug 19. [Epub ahead of print]

Sasaki Y, Sasaki M, Kataoka-Sasaki Y, Nakazaki M, Nagahama H, Suzuki J, Tateyama D, Oka S, Namioka T, Namioka A, Onodera R, Mikami T, Wanibuchi M, Kakizawa M, Ishiai S, Kocsis JD, Honmou O. Synergic Effects of Rehabilitation and Intravenous Infusion of Mesenchymal Stem Cells After Stroke in Rats. Phys Ther. 2016 May 12. [Epub ahead of print]

Nakazaki M, Nonaka T, Takahashi A, Yonemasu Y, Nomura T, Onda T, Honda O, Hashimoto Y, Ohnishi H, Sasaki M, Daibo M, Honmou O. Double balloon protection during carotid artery stenting for vulnerable carotid stenosis reduces the incidence of new brain lesions. Acta Neurochir (Wien). 2016 May 2. [Epub ahead of print]

Ohtaki S, Wanibuchi M, Kataoka-Sasaki Y, Sasaki M, Oka S, Noshiro S, Akiyama Y, Mikami T, Mikuni N, Kocsis JD, Honmou O. ACTC1 as an invasion and prognosis marker in glioma. J Neurosurg. 2016 Apr 15:1-9. [Epub ahead of print]

Takayanagi A, Sasaki M, Kataoka-Sasaki Y, Kobayashi K, Matsuda Y, Oka S, Masumori N, Kocsis JD, Honmou O. Intravenous Preload of Mesenchymal Stem Cells Rescues Erectile Function in a Rat Model of Cavernous Nerve Injury. J Sex Med. 12 (2015): 713-21.

Matsushita T, Lankford KL, Arroyo EJ, Sasaki M, Neyazi M, Radtke C, Kocsis JD. Diffuse and persistent blood-spinal cord barrier disruption after contusive spinal cord injury rapidly recovers following intravenous infusion of bone marrow mesenchymal stem cells. Exp Neurol. 267 (2015) :152-64.

Suzuki S, Kawamata J, Iwahara N, Matsumura A, Hisahara S, Matsushita T, Sasaki M, Honmou O, Shimohama S. Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats. Neurosci Lett. 2015 Jan 1;584:276-81.

Lankford KL, Brown RJ, Sasaki M, Kocsis JD.
Olfactory ensheathing cells, but not Schwann cells, proliferate and migrate extensively within moderately X-irradiated juvenile rat brain.
Glia. 62 (2014) : 52-63.

Suzuki J, Sasaki M, Harada K, Bando M, Kataoka Y, Onodera R, Mikami T, Wanibuchi M, Mikuni N, Kocsis JD, Honmou O.
Bilateral Cortical Hyperactivity Detected by fMRI Associates with Improved Motor Function Following Intravenous Infusion of Mesenchymal Stem Cells in a Rat Stroke Model,
Brain Research 1497 (2013) 15-22

Kocsis JD, Honmou O.
Bone marrow stem cells in experimental stroke.
Prog Brain Res. 2012;201:79-98. doi: 10.1016/B978-0-444-59544-7.00005-6.

Inden M, Takata K, Nishimura K, Kitamura Y, Ashihara E, Yoshimoto K, Ariga H, Honmou O, Shimohama S.
Therapeutic effects of human mesenchymal and hematopoietic stem cells on rotenone-treated parkinsonian mice.
J Neurosci Res. 2013 Jan;91(1):62-72. doi: 10.1002/jnr.23128. Epub 2012 Oct 17.
PMID: 23073839 [PubMed - in process]

Honmou O, Onodera R, Sasaki M, Waxman SG, Kocsis JD.
Mesenchymal stem cells:therapeutic outlook for stroke. Trends Mol Med. 2012 Mar 27.
[Epub ahead of print] PubMed PMID: 22459358.

Sasaki Y, Honmou O. [Bone marrow stem cell therapy for stroke]. Nihon Rinsho.
2011 Dec;69(12):2203-8. Japanese. PubMed PMID: 22242320.

Radtke C, Sasaki M, Lankford KL, Gallo V, Kocsis JD. CNPase expression in
olfactory ensheathing cells. J Biomed Biotechnol. 2011;2011:608496. Epub 2011 Nov
16. PubMed PMID: 22174557; PubMed Central PMCID: PMC3228405.

Katada R, Nishitani Y, Honmou O, Mizuo K, Okazaki S, Tateda K, Watanabe S,
Matsumoto H. Expression of aquaporin-4 augments cytotoxic brain edema after
traumatic brain injury during acute ethanol exposure. Am J Pathol. 2012
Jan;180(1):17-23. Epub 2011 Nov 1. PubMed PMID: 22051773.

Sasaki M, Honmou O, Radtke C, Kocsis JD.
Development of a middle cerebral artery occlusion model in the nonhuman primate and a safety study of i.v. infusion of human mesenchymal stem cells.
PLoS One. 2011;6(10):e26577. Epub 2011 Oct 24. PubMed PMID: 22039510; PubMed Central PMCID: PMC3200343.

Song CH, Honmou O, Furuoka H, Horiuchi M. Identification of chemoattractive
factors involved in the migration of bone marrow-derived mesenchymal stem cells
to brain lesions caused by prions. J Virol. 2011 Nov;85(21):11069-78. Epub 2011
Aug 3. PubMed PMID: 21813601; PubMed Central PMCID: PMC3194951.

Matsushita T, Kibayashi T, Katayama T, Yamashita Y, Suzuki S, Kawamata J,
Honmou O, Minami M, Shimohama S. Mesenchymal stem cells transmigrate across brain
microvascular endothelial cell monolayers through transiently formed
inter-endothelial gaps. Neurosci Lett. 2011 Sep 8;502(1):41-5. Epub 2011 Jul 20.
PubMed PMID: 21798315.

Honmou O, Houkin K, Matsunaga T, Niitsu Y, Ishiai S, Onodera R, Waxman SG,
Kocsis JD. Intravenous administration of auto serum-expanded autologous
mesenchymal stem cells in stroke. Brain. 2011 Jun;134(Pt 6):1790-807. Epub 2011
Apr 14. PubMed PMID: 21493695; PubMed Central PMCID: PMC3102237.

Sasaki M, Lankford KL, Radtke C, Honmou O, Kocsis JD. Remyelination after
olfactory ensheathing cell transplantation into diverse demyelinating
environments. Exp Neurol. 2011 May;229(1):88-98. Epub 2011 Jan 28. Review. PubMed
PMID: 21281634.

Sasaki M, Lankford KL, Brown RJ, Ruddle NH, Kocsis JD. Focal experimental
autoimmune encephalomyelitis in the Lewis rat induced by immunization with myelin
oligodendrocyte glycoprotein and intraspinal injection of vascular endothelial
growth factor. Glia. 2010 Oct;58(13):1523-31. PubMed PMID: 20645414.

Honmou O, Houkin K. [Stem cell therapy for cerebral ischemia]. No Shinkei
Geka. 2010 Jun;38(6):515-20. Review. Japanese. PubMed PMID: 20543224.

Onodera R, Teramukai S, Tanaka S, Kojima S, Horie T, Matoba S, Murohara T,
Matsubara H, Fukushima M; BMMNC Follow-Up Study Investigators; M-PBMNC Follow-Up
Study Investigators. Bone marrow mononuclear cells versus G-CSF-mobilized
peripheral blood mononuclear cells for treatment of lower limb ASO: pooled
analysis for long-term prognosis. Bone Marrow Transplant. 2011 Feb;46(2):278-84.
Epub 2010 May 17. PubMed PMID: 20479708.

Osaka M, Honmou O, Murakami T, Nonaka T, Houkin K, Hamada H, Kocsis JD.
Intravenous administration of mesenchymal stem cells derived from bone marrow
after contusive spinal cord injury improves functional outcome. Brain Res. 2010
Jul 9;1343:226-35. Epub 2010 May 12. PubMed PMID: 20470759.

Komatsu K, Honmou O, Suzuki J, Houkin K, Hamada H, Kocsis JD. Therapeutic
time window of mesenchymal stem cells derived from bone marrow after cerebral
ischemia. Brain Res. 2010 Jun 2;1334:84-92. Epub 2010 Apr 9. PubMed PMID:
20382136.

Kataoka Y, Kalanithi PS, Grantz H, Schwartz ML, Saper C, Leckman JF,
Vaccarino FM. Decreased number of parvalbumin and cholinergic interneurons in the
striatum of individuals with Tourette syndrome. J Comp Neurol. 2010 Feb
1;518(3):277-91. PubMed PMID: 19941350; PubMed Central PMCID: PMC2846837.

Sasaki M, Radtke C, Tan AM, Zhao P, Hamada H, Houkin K, Honmou O, Kocsis JD.
BDNF-hypersecreting human mesenchymal stem cells promote functional recovery,
axonal sprouting, and protection of corticospinal neurons after spinal cord
injury. J Neurosci. 2009 Nov 25;29(47):14932-41. PubMed PMID: 19940189; PubMed
Central PMCID: PMC2825276.

Zheng W, Honmou O, Miyata K, Harada K, Suzuki J, Liu H, Houkin K, Hamada H,
Kocsis JD. Therapeutic benefits of human mesenchymal stem cells derived from bone
marrow after global cerebral ischemia. Brain Res. 2010 Jan 15;1310:8-16. Epub
2009 Nov 12. PubMed PMID: 19913518.

Markakis EA, Sasaki M, Lankford KL, Kocsis JD. Convergence of cells from the
progenitor fraction of adult olfactory bulb tissue to remyelinating glia in
demyelinating spinal cord lesions. PLoS One. 2009 Sep 29;4(9):e7260. PubMed PMID:
19787061; PubMed Central PMCID: PMC2747269.

Horie T, Onodera R, Akamastu M, Ichikawa Y, Hoshino J, Kaneko E, Iwashita C,
Ishida A, Tsukamoto T, Teramukai S, Fukushima M, Kawamura A; Japan Study Group of
Peripheral Vascular Regeneration Cell Therapy (JPRCT). Long-term clinical
outcomes for patients with lower limb ischemia implanted with G-CSF-mobilized
autologous peripheral blood mononuclear cells. Atherosclerosis. 2010
Feb;208(2):461-6. Epub 2009 Aug 3. PubMed PMID: 19720375.

Kawamoto A, Katayama M, Handa N, Kinoshita M, Takano H, Horii M, Sadamoto K,
Yokoyama A, Yamanaka T, Onodera R, Kuroda A, Baba R, Kaneko Y, Tsukie T, Kurimoto
Y, Okada Y, Kihara Y, Morioka S, Fukushima M, Asahara T. Intramuscular
transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb
ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical
trial. Stem Cells. 2009 Nov;27(11):2857-64. PubMed PMID: 19711453.

Katada R, Nishitani Y, Honmou O, Okazaki S, Houkin K, Matsumoto H. Prior
ethanol injection promotes brain edema after traumatic brain injury. J
Neurotrauma. 2009 Nov;26(11):2015-25. PubMed PMID: 19558208.

Kocsis JD, Lankford KL, Sasaki M, Radtke C. Unique in vivo properties of
olfactory ensheathing cells that may contribute to neural repair and protection
following spinal cord injury. Neurosci Lett. 2009 Jun 12;456(3):137-42. Epub 2009
Jan 17. Review. PubMed PMID: 19429149; PubMed Central PMCID: PMC2713444.

Sasaki M, Honmou O, Kocsis JD. A rat middle cerebral artery occlusion model
and intravenous cellular delivery. Methods Mol Biol. 2009;549:187-95. PubMed
PMID: 19378204.

Song CH, Honmou O, Ohsawa N, Nakamura K, Hamada H, Furuoka H, Hasebe R,
Horiuchi M. Effect of transplantation of bone marrow-derived mesenchymal stem
cells on mice infected with prions. J Virol. 2009 Jun;83(11):5918-27. Epub 2009
Mar 18. PubMed PMID: 19297502; PubMed Central PMCID: PMC2681942.

Liu H, Koyanagi I, Chiba H, Wanibuchi M, Honmou O, Yamaki T, Houkin K. Spinal
cord infarct as the initial clinical presentation of intravascular malignant
lymphomatosis. J Clin Neurosci. 2009 Apr;16(4):570-3. Epub 2009 Feb 5. PubMed
PMID: 19200739.

Toyama K, Honmou O, Harada K, Suzuki J, Houkin K, Hamada H, Kocsis JD.
Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells
after cerebral ischemia. Exp Neurol. 2009 Mar;216(1):47-55. Epub 2008 Nov 27.
PubMed PMID: 19094989.

Matoba S, Tatsumi T, Murohara T, Imaizumi T, Katsuda Y, Ito M, Saito Y,
Uemura S, Suzuki H, Fukumoto S, Yamamoto Y, Onodera R, Teramukai S, Fukushima M, Matsubara H; TACT Follow-up Study Investigators. Long-term clinical outcome after
intramuscular implantation of bone marrow mononuclear cells (Therapeutic
Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb
ischemia. Am Heart J. 2008 Nov;156(5):1010-8. Epub 2008 Sep 19. PubMed PMID:
19061721.

Omori Y, Honmou O, Harada K, Suzuki J, Houkin K, Kocsis JD. Optimization of a
therapeutic protocol for intravenous injection of human mesenchymal stem cells
after cerebral ischemia in adult rats. Brain Res. 2008 Oct 21;1236:30-8. Epub
2008 Aug 9. PubMed PMID: 18722359; PubMed Central PMCID: PMC2605387.

Radtke C, Sasaki M, Lankford KL, Vogt PM, Kocsis JD. Potential of olfactory
ensheathing cells for cell-based therapy in spinal cord injury. J Rehabil Res
Dev. 2008;45(1):141-51. Review. PubMed PMID: 18566933.

Lankford KL, Sasaki M, Radtke C, Kocsis JD. Olfactory ensheathing cells
exhibit unique migratory, phagocytic, and myelinating properties in the
X-irradiated spinal cord not shared by Schwann cells. Glia. 2008 Nov
15;56(15):1664-78. PubMed PMID: 18551623.

Saito F, Nakatani T, Iwase M, Maeda Y, Hirakawa A, Murao Y, Suzuki Y, Onodera
R, Fukushima M, Ide C. Spinal cord injury treatment with intrathecal autologous
bone marrow stromal cell transplantation: the first clinical trial case report. J
Trauma. 2008 Jan;64(1):53-9. PubMed PMID: 18188099.

Marui A, Tabata Y, Kojima S, Yamamoto M, Tambara K, Nishina T, Saji Y, Inui
K, Hashida T, Yokoyama S, Onodera R, Ikeda T, Fukushima M, Komeda M. A novel
approach to therapeutic angiogenesis for patients with critical limb ischemia by
sustained release of basic fibroblast growth factor using biodegradable gelatin
hydrogel: an initial report of the phase I-IIa study. Circ J. 2007
Aug;71(8):1181-6. PubMed PMID: 17652878.

Onda T, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. Therapeutic
benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs
after cerebral ischemia. J Cereb Blood Flow Metab. 2008 Feb;28(2):329-40. Epub
2007 Jul 18. PubMed PMID: 17637706; PubMed Central PMCID: PMC2605394.

Sasaki M, Li B, Lankford KL, Radtke C, Kocsis JD. Remyelination of the
injured spinal cord. Prog Brain Res. 2007;161:419-33. Review. PubMed PMID:
17618995; PubMed Central PMCID: PMC2605400.

Honmou O, Houkin K. [A cell therapy for stroke]. Nihon Rinsho. 2006 Oct 28;64
Suppl 7:664-6. Review. Japanese. PubMed PMID: 17461219.

Radtke C, Spies M, Sasaki M, Vogt PM, Kocsis JD. Demyelinating diseases and
potential repair strategies. Int J Dev Neurosci. 2007 May;25(3):149-53. Epub 2007
Mar 3. Review. PubMed PMID: 17408905; PubMed Central PMCID: PMC2692731.

Ukai R, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. Mesenchymal stem
cells derived from peripheral blood protects against ischemia. J Neurotrauma.
2007 Mar;24(3):508-20. PubMed PMID: 17402856; PubMed Central PMCID: PMC2605398.

Harada K, Honmou O, Liu H, Bando M, Houkin K, Kocsis JD. Magnetic resonance
lactate and lipid signals in rat brain after middle cerebral artery occlusion
model. Brain Res. 2007 Feb 23;1134(1):206-13. Epub 2006 Dec 29. PubMed PMID:
17196558; PubMed Central PMCID: PMC2605392.

Harada K, Honmou O, Odawara Y, Bando M, Houkin K. Optimization of
three-dimensional time-of-flight magnetic resonance angiography of the
intracranial arteries. Neurol Med Chir (Tokyo). 2006 Nov;46(11):523-8; discussion
528. PubMed PMID: 17124366.

Dombrowski MA, Sasaki M, Lankford KL, Kocsis JD, Radtke C. Myelination and
nodal formation of regenerated peripheral nerve fibers following transplantation
of acutely prepared olfactory ensheathing cells. Brain Res. 2006 Dec
13;1125(1):1-8. Epub 2006 Nov 16. PubMed PMID: 17112480; PubMed Central PMCID:
PMC2673087.

Kim S, Honmou O, Kato K, Nonaka T, Houkin K, Hamada H, Kocsis JD. Neural
differentiation potential of peripheral blood- and bone-marrow-derived precursor
cells. Brain Res. 2006 Dec 6;1123(1):27-33. Epub 2006 Oct 24. PubMed PMID:
17064670; PubMed Central PMCID: PMC2605382.

Horita Y, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. Intravenous
administration of glial cell line-derived neurotrophic factor gene-modified human
mesenchymal stem cells protects against injury in a cerebral ischemia model in
the adult rat. J Neurosci Res. 2006 Nov 15;84(7):1495-504. PubMed PMID: 16998918;
PubMed Central PMCID: PMC2605367.

Liu H, Honmou O, Harada K, Nakamura K, Houkin K, Hamada H, Kocsis JD.
Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral
ischaemia. Brain. 2006 Oct;129(Pt 10):2734-45. Epub 2006 Aug 10. PubMed PMID:
16901914; PubMed Central PMCID: PMC2605397.

Sasaki M, Black JA, Lankford KL, Tokuno HA, Waxman SG, Kocsis JD. Molecular
reconstruction of nodes of Ranvier after remyelination by transplanted olfactory
ensheathing cells in the demyelinated spinal cord. J Neurosci. 2006 Feb
8;26(6):1803-12. PubMed PMID: 16467529; PubMed Central PMCID: PMC2605396.

Sasaki M, Hains BC, Lankford KL, Waxman SG, Kocsis JD. Protection of
corticospinal tract neurons after dorsal spinal cord transection and engraftment
of olfactory ensheathing cells. Glia. 2006 Mar;53(4):352-9. PubMed PMID:
16288464; PubMed Central PMCID: PMC2605395.

Nomura T, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. I.V. infusion of
brain-derived neurotrophic factor gene-modified human mesenchymal stem cells
protects against injury in a cerebral ischemia model in adult rat. Neuroscience.
2005;136(1):161-9. Epub 2005 Oct 17. PubMed PMID: 16229956; PubMed Central PMCID:
PMC2605391.

Kalanithi PS, Zheng W, Kataoka Y, DiFiglia M, Grantz H, Saper CB, Schwartz
ML, Leckman JF, Vaccarino FM. Altered parvalbumin-positive neuron distribution in
basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci U S A.
2005 Sep 13;102(37):13307-12. Epub 2005 Aug 30. PubMed PMID: 16131542; PubMed
Central PMCID: PMC1201574.

Honma T, Honmou O, Iihoshi S, Harada K, Houkin K, Hamada H, Kocsis JD.
Intravenous infusion of immortalized human mesenchymal stem cells protects
against injury in a cerebral ischemia model in adult rat. Exp Neurol. 2006
May;199(1):56-66. Epub 2005 Jun 20. PubMed PMID: 15967439; PubMed Central PMCID:
PMC2605388.

Hamada H, Kobune M, Nakamura K, Kawano Y, Kato K, Honmou O, Houkin K,
Matsunaga T, Niitsu Y. Mesenchymal stem cells (MSC) as therapeutic cytoreagents
for gene therapy. Cancer Sci. 2005 Mar;96(3):149-56. Review. PubMed PMID:
15771617.

Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Ishii K, Kobune M, Hirai S,
Uchida H, Sasaki K, Ito Y, Kato K, Honmou O, Houkin K, Date I, Hamada H.
Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage
in the rat middle cerebral artery occlusion model. Mol Ther. 2005
Jan;11(1):96-104. PubMed PMID: 15585410.

Oka S, Honmou O, Akiyama Y, Sasaki M, Houkin K, Hashi K, Kocsis JD.
Autologous transplantation of expanded neural precursor cells into the
demyelinated monkey spinal cord. Brain Res. 2004 Dec 24;1030(1):94-102. PubMed
PMID: 15567341.

Sasaki M, Lankford KL, Zemedkun M, Kocsis JD. Identified olfactory
ensheathing cells transplanted into the transected dorsal funiculus bridge the
lesion and form myelin. J Neurosci. 2004 Sep 29;24(39):8485-93. PubMed PMID:
15456822; PubMed Central PMCID: PMC2605369.

Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, Tsuda H, Bizen A, Honmou
O, Niitsu Y, Hamada H. Antitumor effect of genetically engineered mesenchymal
stem cells in a rat glioma model. Gene Ther. 2004 Jul;11(14):1155-64. PubMed
PMID: 15141157.

Iihoshi S, Honmou O, Houkin K, Hashi K, Kocsis JD. A therapeutic window for
intravenous administration of autologous bone marrow after cerebral ischemia in
adult rats. Brain Res. 2004 May 8;1007(1-2):1-9. PubMed PMID: 15064130.

Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Kobune M, Hirai S, Uchida H,
Sasaki K, Ito Y, Kato K, Honmou O, Houkin K, Date I, Hamada H. BDNF gene-modified
mesenchymal stem cells promote functional recovery and reduce infarct size in the
rat middle cerebral artery occlusion model. Mol Ther. 2004 Feb;9(2):189-97.
Erratum in: Mol Ther. 2004 May;9(5):766. PubMed PMID: 14759803.

Inoue M, Honmou O, Oka S, Houkin K, Hashi K, Kocsis JD. Comparative analysis
of remyelinating potential of focal and intravenous administration of autologous
bone marrow cells into the rat demyelinated spinal cord. Glia. 2003
Nov;44(2):111-8. PubMed PMID: 14515327; PubMed Central PMCID: PMC2605389.

Kobune M, Kawano Y, Ito Y, Chiba H, Nakamura K, Tsuda H, Sasaki K, Dehari H,
Uchida H, Honmou O, Takahashi S, Bizen A, Takimoto R, Matsunaga T, Kato J, Kato
K, Houkin K, Niitsu Y, Hamada H. Telomerized human multipotent mesenchymal cells
can differentiate into hematopoietic and cobblestone area-supporting cells. Exp
Hematol. 2003 Aug;31(8):715-22. PubMed PMID: 12901977.

Tanaka H, Hata F, Nishimori H, Honmou O, Yasoshima T, Nomura H, Ohno K, Hirai
I, Kamiguchi K, Isomura H, Hirohashi Y, Denno R, Sato N, Hirata K. Differential
gene expression screening between parental and highly metastatic pancreatic
cancer variants using a DNA microarray. J Exp Clin Cancer Res. 2003
Jun;22(2):307-13. PubMed PMID: 12866582.

Akiyama Y, Radtke C, Honmou O, Kocsis JD. Remyelination of the spinal cord
following intravenous delivery of bone marrow cells. Glia. 2002 Sep;39(3):229-36.
PubMed PMID: 12203389; PubMed Central PMCID: PMC2605380.

Lankford KL, Imaizumi T, Honmou O, Kocsis JD. A quantitative morphometric
analysis of rat spinal cord remyelination following transplantation of allogenic
Schwann cells. J Comp Neurol. 2002 Feb 11;443(3):259-74. PubMed PMID: 11807836;
PubMed Central PMCID: PMC2605379.

Sasaki M, Honmou O, Akiyama Y, Uede T, Hashi K, Kocsis JD. Transplantation of
an acutely isolated bone marrow fraction repairs demyelinated adult rat spinal
cord axons. Glia. 2001 Jul;35(1):26-34. PubMed PMID: 11424189; PubMed Central
PMCID: PMC2605363.